Stay Updated with the Latest Talmora Diamond Inc. TAI.CN News in Real Time
Find TAI.CN news now at Meyka AI. Stay informed with the latest Talmora Diamond Inc. stocks updates, including price news, market analysis, and expert insights.
Baidu (NASDAQ: BIDU) Shares Surge 7% After Report Says AI Chip Unit Kunlunxin Targets $50 Billion Valuation in Hong Kong IPO
Baidu shares surged nearly 7% on June 29, 2026, after reports revealed that its AI chip subsidiary, Kunlunxin, is targeting a Hong Kong IPO with a valuation of up to $50 billion. The news has sparked strong investor interest and renewed attention on China’s rapidly expanding AI semiconductor sector. As competition in artificial intelligence intensifies…
GOOG Stock Today: Alphabet Inc. Class C Drops 2.19% Despite TrueMark Investments LLC’s New Investment
GOOG stock faced fresh selling pressure on June 28, 2026, even as institutional interest stayed intact. TrueMark Investments LLC purchased a brand-new position in Alphabet Inc. Class C during Q1 2026, filing its disclosure via Form 13F with the SEC. GOOG opened the session at $340.98 on June 29, trading in a range of $333.69…
S&P 500, Dow Futures Rise Despite Big Tech Losses and Hot Inflation; AAPL, MSFT, BABA in Focus
U.S. stock market futures edged higher on June 27, 2026, even as major technology stocks faced renewed selling pressure and fresh inflation data came in hotter-than-expected. The surprising market resilience has shifted investors’ attention to whether the broader rally can continue despite concerns over interest rates. At the center of the action are Apple (AAPL),…
Nike Inc (NYSE: NKE) Stock Drops Ahead of Q4 Earnings as Surprise CFO Change Raises Turnaround Questions
Nike Inc chose the worst possible timing for a leadership change. Nike Inc (NYSE: NKE) announced on June 23, 2026, that CFO Matthew Friend will step down effective August 17, to be replaced by David M. Denton as incoming Chief Financial Officer. NKE traded near $45.20 as of June 15, already 44% below its 52-week…
New Zealand shares -0.26% S&P/NZX 50 Index, Nvidia -4%, AMD -6% Nasdaq Composite -2%, S&P 500 -1%
Global markets faced fresh pressure on June 24, 2026, as a sharp selloff in semiconductor stocks rattled investor sentiment. NVIDIA fell around 4%, while AMD dropped nearly 6%, dragging the Nasdaq Composite down about 2% and the S&P 500 lower by 1%. The weakness also spread to Asia, with New Zealand’s S&P/NZX 50 Index slipping…
Qualcomm Inc (NASDAQ: QCOM) Loses 1.86% to $221.90 as AI Expansion Gains Momentum but Stock Faces Pressure
Qualcomm Inc (NASDAQ: QCOM) pulled back 1.86% to $221.90 on June 23, 2026, even as its AI and automotive expansion story grows more concrete by the quarter. The stock trades within a 52-week range of $121.99 to $259.92, reflecting a sharp recovery from lows but still well off its all-time closing high of $250.10 from…
Tesla Inc Shares (NASDAQ: TSLA) up +1.14% After Jefferies Lowers Target to $375 Amid SpaceX Merger Talk
Tesla Inc. shares climbed 1.14% after analysts at Jefferies lowered their price target to $375, drawing fresh attention to the company’s future growth path. The move comes as investors closely watch rising speculation about a possible Tesla-SpaceX merger, a topic that has sparked intense debate across Wall Street in June 2026. While some see major…
Robinhood (NASDAQ: HOOD) Shares Slide 4% After Unveiling $2 Billion Convertible Notes Offering Due 2029
Robinhood shares dropped roughly 4% on June 22, 2026, after the company announced a major capital raise before market open. Robinhood Markets, Inc. (NASDAQ: HOOD) intends to offer $2.0 billion in convertible senior notes due 2029 in a private placement to qualified institutional buyers under Rule 144A. Shares traded at $108.15 on June 22, within…
AbbVie to Acquire Apogee Therapeutics in $10.9 Billion Deal, Offering Nearly 50% Premium
AbbVie made a major move in the biotech sector on June 22, 2026, announcing a $10.9 billion deal to acquire Apogee Therapeutics. The transaction offers Apogee shareholders nearly a 50% premium and gives AbbVie access to a promising pipeline of immunology treatments. As competition grows in the market for inflammatory disease therapies, this acquisition could…